Parathyroid Neoplasms

Approved for this indication (1)

• cinacalcet

Phase 4 trials (4)

• acetaminophen
• lidocaine
• tramadol
• codeine

Phase 3 trials (4)

• fluorocholine
• denosumab
• sodium chloride
• evocalcet

Phase 2 trials (3)

• gallium-68-dotatate
• fluorodopa
• nivolumab

Phase 1 trials (4)

• epinephrine
• bupivacaine
• bortezomib
• dacarbazine

Other trials (1)

• fluoromethylcholine (18f)

Organization Involved with Phase 4 Indications (3)

• Amgen
• Doctors Hospital at Renaissance
• Saint-Petersburg State Medical University

Organization Involved with Phase 3 Indications (3)

• Kyowa Hakko Kirin
• Aalborg University
• University of California, San Francisco

Organization Involved with Phase 2 Indications (1)

• University of Caen-Normandie

Organization Involved with Phase 1 Indications (4)

• National Cancer Institute (NCI)
• Ohio State University
• Virginia Commonwealth University
• University of Missouri

Organization Involved with Other Experimental Indications (2)

• Emory University
• Southwest Oncology Group